1 / 40

DIAGNOSIS IN DIFFUSE ALVEOLAR HEMORRHAGES

DIAGNOSIS IN DIFFUSE ALVEOLAR HEMORRHAGES. Demet KARNAK, MD, Professor Ankara University School of Medicine Chest Disease Department. DIFFUSE ALVEOLAR HEMORRHAGES. Hemorrhage to alveolar spaces Alveolo-capillary membrane d a mage

tab
Download Presentation

DIAGNOSIS IN DIFFUSE ALVEOLAR HEMORRHAGES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. DIAGNOSIS IN DIFFUSE ALVEOLAR HEMORRHAGES Demet KARNAK, MD, Professor Ankara University School of Medicine Chest Disease Department

  2. DIFFUSE ALVEOLAR HEMORRHAGES • Hemorrhage to alveolar spaces • Alveolo-capillary membrane damage • Damage to arterioles-venules and alveolar septal lines along with tears in capillaries around these areas • Even if excess hemorrhage exist, hemoptysis can be absent?

  3. ETIOLOGY and HISTOLOGY • Pulmonary capillaritis • Bland Pulmonary Hemorrhage  • Diffuse Alveolar Damage

  4. Pulmonary capillaritis • Interstitial neutrophilic infitration reflecting alveolar septas • Rapid necrosis, advanced structural discrepancies and red blood cell invasion in the alveolar spaces • Neutrophils fragment in a short while • Toxic oxygen radicals can be the cause ? • Fragmented neutrophils, nuclear dust and fibrine migrate to the alveolar space leading to fibrinoid necrosis

  5. Pulmonary capillaritis

  6. Capillaritis

  7. Bland Pulmonary Hemorrhage • Alveolar hemorrhage without inflammation and destruction

  8. Bland Pulmonary Hemorrhage

  9. Diffuse Alveolar Damage • Underliying form of acute respiratory distress syndrome • Characterized by alveolar septal edema and hyaline membrane formation • This scenario is also DAH

  10. Diffuse Alveolar Damage

  11. Diffuse Alveolar Damage

  12. Connective Tissue Disease

  13. Other Diseases

  14. Other Diseases

  15. CLINICAL PRESENTATION • Dyspnea • Hemoptysis • Increased alveolo-arterial oxygen gradient • Anemia • Diffuse alveolar pattern-in chest x-ray • DLCO (first 48 h) • BAL findings

  16. DAH-Chest x-ray

  17. Bronchoscopy • Hemorrhagic feature of the BAL fluid • hemosiderin pigment in alveolar macrophages (prussian blue) • Exclude DAH if BAL findings are absent • TBB can be helpful in differential diagnosis especially in granulomatous disease or vasculitis

  18. CLINICAL VIEW

  19. HISTORY • Drug addiction • Connective Tissue disease • İmmune status • Vasculitic symptoms • Cardiac pathologies

  20. SYMPTOMS and SIGNS • Usually no more than a week • Cough, dypnea, fever are the most common symptoms • Meed of mechanic ventilation in some cases • Hemoptysis can be absent in 33% on the first presentation • Localized or diffuse alveolar infiltration, Hb drop and hemorrhagic BAL fluid can suggestive for DAH

  21. PHYSICAL EXAMINATION • Usually nonspecific • Difficult to diagnose if there is no underlying disease such as vasculitis or connective tissue disease! • Uveitis or leukocytoclastic vasculitis collagen vascular disease, mitral stenosis can be easily caught!

  22. RADIOLOGY • Chest X-ray can be non-spesific • Diffuse patchy alveolar opacities • Recurrent DAH episodes- lung fibrosis and persistent interstitiel infiltrates • COPD+DAH • MPA+DAH

  23. LABORATORY ANALYSES • ESR • Leukocytes • HTC • Pulmonary-renal disease • Glomerulonephritis • Elevated plasma creatinin concentration • Urinalysis: Proteinuria, leukocytes and erithrocytes

  24. DAH TRIAD FOR DIAGNOSIS • Gas exchange abnormalities-hypoxemia • Need of mechanical ventilation ?! • Increased DLCO • Dıffuse alveolar infiltration

  25. SPECIAL OCCASIONS • ANCA antibodies can be helpful in the diagnosis of Wegener Granulomatosis, MPA, idiopathic pulmonary-renal syndrome • Cytoplasmic ANCA (c-ANCA), reflects antiproteinase 3 (PR 3) and mostly specific for Wegener Granulomatosis • Perinuclear ANCA (p-ANCA) reflects anti-myeloperoksidase antibody and meaningful in the diagnosis of MPA and idiopathic pulmonary-renal syndrome

  26. SPECIAL OCCASIONS • Untreated SLE cases has 95% ANA antibody positivity • Anti-ds DNA, is positive in the 50-75% of the cases • Anti-ds DNA positivity and decreased C3 level is 100% diagnostic for SLE • Tissue immunoflorescent studies and serum ABMA (antiglomerular basal membrane antibody) measurement is 97% sensitive and 98% specific for Goodpasture syndrome

  27. TREATMENT • Different according to underlying etiology

  28. PROGNOSIS • Recurrent episodes cause to irreversible pulmonary fibrosis • Idiopathic pulmonary hemosiderosis, wegener, and mitral stenosis can be examples of this scenario • After DAH, severe obstructive pulmonary damage and emphysema were reported

  29. MORTALITY • Related to underlying cause • SLE, anti-GBM disease and Idiopathic pulmonary hemosiderosis has 25-50% early mortality rate

  30. Mortality

  31. 35 year old female High fever, night sweeting, trembling and fatigue for ten days Severe dypnea for 2 days Loss of weight 7kg/month Hypertyroidism 6 year ago, taking PTU pills Beta-blocking agent Anti-depressant DAH-PTU

  32. 1. Ay kontrol 6. Ay kontrol

  33. 6. Ay kontrol BT

  34. DAH-CMV pneumonia

  35. DAH-MPA

  36. SAH-MPA

  37. DAH-CMP

More Related